Active Surveillance in Prostate Cancer: New Efforts, New Voices, New Hope

Por BASOURAKOS, SPYRIDON P., HOFFMAN, KAREN, KIM, JERI
Publicado no BJU Int (2017)

Cixutumumab-Associated Pancolitis in a Prostate Cancer Patient

Por Bilen, Mehmet Asim, Kim, Jeri, Wang, Huamin, Tu, Shi-Ming
Publicado em 2012

LINE-1 methylation in peripheral blood leukocytes and clinical characteristics and prognosis of prostate cancer patients

Por Han, Yuyan, Xu, Junfeng, Kim, Jeri, Wu, Xifeng, Gu, Jian
Publicado no Oncotarget (2017)

Methylation of subtelomeric repeat D4Z4 in peripheral blood leukocytes is associated with biochemical recurrence in localized prostate cancer patients

Por Han, Yuyan, Xu, Junfeng, Kim, Jeri, Wu, Xifeng, Gu, Jian
Publicado no Carcinogenesis (2017)

The Prostate Cancer Susceptibility Variant rs2735839 Near KLK3 Gene Is Associated with Aggressive Prostate Cancer and Can Stratify Gleason Score 7 Patients

Por He, Yonggang, Gu, Jian, Strom, Sara, Logothetis, Christopher J., Kim, Jeri, Wu, Xifeng
Publicado em 2014

Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions

Por Basourakos, Spyridon P., Li, Likun, Aparicio, Ana M., Corn, Paul G., Kim, Jeri, Thompson, Timothy C.
Publicado no Curr Med Chem (2017)

Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution...

Por Davis, John W., Kim, Jeri, Ward, John F., Wang, Xuemai, Nakanishi, Hiro, Babaian, R. Joseph, Troncoso, Patricia
Publicado no BJU Int (2009)

Molecular Classification of Prostate Cancer Progression: Foundation for Marker driven-Treatment of Prostate Cancer

Por Logothetis, Christopher J, Gallick, Gary E., Maity, Sankar N., Kim, Jeri, Aparicio, Ana, Efstathiou, Eleni, Lin, Sue-Hwa
Publicado em 2013

Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned

Por Lowenstein, Lisa M., Basourakos, Spyridon P., Williams, Michelle D., Troncoso, Patricia, Gregg, Justin R., Thompson, Timothy C., Kim, Jeri
Publicado no Nat Rev Clin Oncol (2019)

PTEN Deficiency Is Fully Penetrant for Prostate Adenocarcinoma in C57BL/6 Mice via mTOR-Dependent Growth

Por Blando, Jorge, Portis, Melisa, Benavides, Fernando, Alexander, Angela, Mills, Gordon, Dave, Bhuvanesh, Conti, Claudio J., Kim, Jeri, Walker, Cheryl Lyn
Publicado em 2009

Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance

Por Gregg, Justin R., Zheng, Jiali, Lopez, David S., Reichard, Chad, Browman, Gladys, Chapin, Brian, Kim, Jeri, Davis, John, Daniel, Carrie R.
Publicado no Br J Cancer (2019)

Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillance

Por Shu, Xiang, Ye, Yuanqing, Gu, Jian, He, Yonggang, Davis, John W., Thompson, Timothy C., Logothetis, Christopher J., Kim, Jeri, Wu, Xifeng
Publicado no Carcinogenesis (2016)

Androgen Regulation of 5α-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention

Por Li, Jin, Ding, Zhiyong, Wang, Zhengxin, Lu, Jing-Fang, Maity, Sankar N., Navone, Nora M., Logothetis, Christopher J., Mills, Gordon B., Kim, Jeri
Publicado em 2011

Arachidonic acid metabolism in human prostate cancer

Por YANG, PEIYING, CARTWRIGHT, CARRIE A., LI, JIN, WEN, SIJIN, PROKHOROVA, INA N., SHUREIQI, IMAD, TRONCOSO, PATRICIA, NAVONE, NORA M., NEWMAN, ROBERT A., KIM, JERI
Publicado em 2012

Increasing rates of low-risk prostate cancer incidence in USAF servicemen and selection of treatments

Por del Junco, Deborah J., Fox, Erin E., Cooper, Sharon, Goldhagen, Marc, Koda, Erik, Rogers, David, Canby-Hagino, Edith, Kim, Jeri, Pettaway, Curtis, Boyd, Douglas D.
Publicado em 2011

Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer

Por Tu, Huakang, Gu, Jian, Meng, Qing H., Kim, Jeri, Davis, John W., He, Yonggang, Wagar, Elizabeth A., Thompson, Timothy C., Logothetis, Christopher J., Wu, Xifeng
Publicado no Oncotarget (2015)

Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort

Por Wang, Qinchuan, Gregg, Justin R., Gu, Jian, Ye, Yuanqing, Chang, David W., Davis, John W., Thompson, Timothy C., Kim, Jeri, Logothetis, Christopher J., Wu, Xifeng
Publicado no Oncoimmunology (2018)

Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer

Por Tu, Huakang, Gu, Jian, Meng, Qing H., Kim, Jeri, Strom, Sara, Davis, John W., He, Yonggang, Wagar, Elizabeth A., Thompson, Timothy C., Logothetis, Christopher J., Wu, Xifeng
Publicado no Oncol Lett (2017)

Safety of Same-Day Pegfilgrastim Administration in Metastatic Castration-Resistant Prostate Cancer Treated With Cabazitaxel With Or Without Carboplatin

Por Bilen, Mehmet Asim, Cauley, Diana H., Atkinson, Bradley J., Chen, Hsiang-Chun, Kaya, Diana H., Wang, Xuemei, Vikram, Raghu, Tu, Shi-Ming, Corn, Paul G., Kim, Jeri
Publicado no Clin Genitourin Cancer (2016)

The Relationship Between Illness Uncertainty, Anxiety, Fear of Progression, and Quality of Life in Men With Favorable Risk Prostate Cancer Undergoing Active Surveillance

Por Parker, Patricia A., Davis, John W., Latini, David M., Baum, George, Wang, Xuemei, Ward, John F., Kuban, Deborah, Frank, Steven J., Lee, Andrew K., Logothetis, Christopher J., Kim, Jeri
Publicado no BJU Int (2015)